HuGE Literature Finder
Records 1-11
|
Relationship between
Molecular and clinical oncology 2021 Jan 14 (1): 15. Moscatello Carmelo, Di Nicola Marta, Veschi Serena, Di Gregorio Patrizia, Cianchetti Ettore, Stuppia Liborio, Battista Pasquale, Cama Alessandro, Curia Maria Cristina, Aceto Gitana Mar |
|
Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer.
Human mutation 2020 Dec . Felicio Paula S, Grasel Rebeca S, Campacci Natalia, de Paula Andre E, Galvão Henrique C R, Torrezan Giovana T, Sabato Cristina S, Fernandes Gabriela C, Souza Cristiano P, Michelli Rodrigo D, Andrade Carlos E, Barros Bruna Durães de Figueiredo, Matsushita Marcus M, Revil Timothée, Ragoussis Jiannis, Couch Fergus J, Hart Steven N, Reis Rui M, Melendez Matias E, Tonin Patricia N, Carraro Dirce M, Palmero Edenir |
|
Exon splicing analysis of intronic variants in multi-gene cancer panel testing for hereditary breast/ovarian cancer.
Cancer science 2020 Aug . Ryu Jin-Sun, Lee Hye-Young, Cho Eun Hae, Yoon Kyong-Ah, Kim Min-Kyeong, Joo Jungnam, Lee Eun-Sook, Kang Han-Sung, Lee Seeyoun, Lee Dong Ock, Lim Myong Cheol, Kong Sun-You |
|
A comprehensive custom panel evaluation for routine hereditary cancer testing: improving the yield of germline mutation detection.
Journal of translational medicine 2020 Jun 18 (1): 232. Velázquez Carolina, Lastra Enrique, Avila Cobos Francisco, Abella Luis, de la Cruz Virginia, Hernando Blanca Ascensión, Hernández Lara, Martínez Noemí, Infante Mar, Durán Merced |
|
Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer: a prospective cohort study.
Journal of ovarian research 2019 Aug 12 (1): 80. Li Wenhui, Shao Di, Li Lei, Wu Ming, Ma Shuiqing, Tan Xianjie, Zhong Sen, Guo Fengming, Wang Zhe, Ye Mingz |
|
High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population.
Hereditary cancer in clinical practice 2018 16 12. Maksimenko J, Irmejs A, Trofimovi?s G, B?rzi?a D, Skuja E, Purkalne G, Miklaševi?s E, Gardovskis |
|
High-risk epithelial ovarian cancer patients for hereditary ovarian cancer.
The journal of obstetrics and gynaecology research 2017 Feb . Chirasophon Seksit, Manchana Tarinee, Teerapakpinyo Chinacho |
|
Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer (HBOC) Genes in Patients Lacking known BRCA Mutations.
Human mutation 2016 Feb . Caminsky Natasha G, Mucaki Eliseos J, Perri Ami M, Lu Ruipeng, Knoll Joan H M, Rogan Peter |
|
Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH.
International journal of cancer 2016 10 139 (7): 1557-63. Win Aung Ko, Reece Jeanette C, Dowty James G, Buchanan Daniel D, Clendenning Mark, Rosty Christophe, Southey Melissa C, Young Joanne P, Cleary Sean P, Kim Hyeja, Cotterchio Michelle, Macrae Finlay A, Tucker Katherine M, Baron John A, Burnett Terrilea, Le Marchand Loïc, Casey Graham, Haile Robert W, Newcomb Polly A, Thibodeau Stephen N, Hopper John L, Gallinger Steven, Winship Ingrid M, Lindor Noralane M, Jenkins Mark |
|
Pharmacogenomic assessment of cisplatin-based chemotherapy outcomes in ovarian cancer.
Pharmacogenomics 2014 Feb 15 (3): 329-37. Khrunin Andrey V, Khokhrin Denis V, Moisseev Alexey A, Gorbunova Vera A, Limborska Svetlana |
|
Design and validation of an oligonucleotide microarray for the detection of genomic rearrangements associated with common hereditary cancer syndromes.
Journal of experimental & clinical cancer research : CR 2014 33 74. Mancini-DiNardo Debora, Judkins Thaddeus, Woolstenhulme Nick, Burton Collin, Schoenberger Jeremy, Ryder Matthew, Murray Adam, Gutin Natalia, Theisen Aaron, Holladay Jayson, Craft Jonathan, Arnell Christopher, Moyes Kelsey, Roa Benjam |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 19, 2021
- Content source: